Novel antidiabetic agents and the risk of respiratory diseases: a systematic review and meta-analysis of 27 randomized controlled trials
IntroductionPatients with type 2 diabetes (T2D) are at increased risk of respiratory diseases, but the effects of novel glucose-lowering drugs on respiratory diseases remain unclear.MethodWe conducted a systematic review and meta-analysis of 27 large randomized controlled trials (202,727 participant...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2026-01-01
|
| coleção: | Frontiers in Medicine |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1721311/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|